Biological products for seed processing, such as pollinators, biocontrollers and biostimulants, are based on microorganisms and their metabolites, plant extracts and other natural materials. The global market for biological seed processing is expected to grow from $600 million in 2020 to $1.6 billion in 2030.
The collaboration between Bioceres and Syngenta is based on a Successful business relationship for more than 20 years in Argentina. Under the agreement*, Syngenta Seedcare will become Exclusive distributor Global marketing of Bioceres seed biological processing solutions, with the exception of Argentina, where it will continue to cooperate under the current framework.
As part of the long-term research and development cooperation, the companies will jointly undertake the implementation of New product developmentwith file acceleration Product Registration which is already in the development stage.
Jonathan BrownSyngenta Seedcare Global Director, said, “The agreement with Bioceres enhances our strategy of offering growers more complementary options. pest resistance management s Improving crop health. Thanks to our longstanding relationship with Bioceres, we are fully committed to providing farmers More sustainable innovations To further improve seed health.”
This ad displays a file The value of our commercial offer And our research and development capabilities, greatly expanding and accelerating our ability to Reach more producers With Syngenta Seedcare’s global reach,” Bioceres CEO emphasized, Federico Trucco.
“Organic products play an important role in bringing new solutions to farmers Increase crop yield And at the same time reduce ecological footprint for cultivation. We believe this collaboration with Syngenta will allow us to move more quickly towards those goals simultaneously A great global need for new solutionsTruco has been added.
Syngenta Seedcare and Bioceres will expand their cooperation in key markets such as Brazil and ChinaAs well as in other regions of the world. Implementation of the Agreement will be subject to regulatory approvals.
*Bioceres will retain global rights to use its biological solutions in HB4® crops, which have been modified to better withstand drought events. The portfolio of Marrone Bio Innovations, which was recently acquired by Bioceres and marketed by ProFarm Group, a major subsidiary of Bioceres, is also outside the scope of the current agreement.